CAS 1206799-15-6: Merestinib
Synonyms:- N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide
- MET inhibitor
Sort by
Found 5 products.
N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide
CAS:Formula:C30H22F2N6O3Purity:98%Color and Shape:SolidMolecular weight:552.5309Merestinib
CAS:Merestinib (LY2801653) is an orally available, small molecule inhibitor of the proto-oncogene c-Met (Ki: 2 nM) with potential antineoplastic activity.Formula:C30H22F2N6O3Purity:95% - 99.56%Color and Shape:SolidMolecular weight:552.53Ref: TM-T3455
1mg49.00€2mg70.00€5mg105.00€10mg144.00€25mg254.00€50mg424.00€100mg605.00€500mg1,264.00€1mL*10mM (DMSO)126.00€N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecar boxamide
CAS:N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl2 -oxo3 -pyridinecarboxamide is a small molecule that inhibits the activity of epidermal growth factor receptor (EGFR) kinase domains. It has been shown to have antitumor response in clinical trials and also has clinical relevance for the treatment of malignant brain tumors. This drug has been shown to be effective against metastatic colorectal cancer.Formula:C30H22F2N6O3Purity:Min. 95%Molecular weight:552.53 g/mol
![N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-di…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA003AMN.jpg&w=3840&q=75)
![N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-di…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FFF103891.jpg&w=3840&q=75)
